Pharmagen Inc. (OTCMKTS:PHRX) Stock Short Interest Report for September

Pharmagen Inc. (OTCMKTS:PHRX – Get Free Report) was the recipient of a significant increase in short interest in September. As of September 30th, there was short interest totaling 7,400 shares. Based on an average trading volume of 1,000 shares, the days-to-cover ratio is presently 7.4 days.

Pharmagen Price Performance

Pharmagen has a 1-year low of $0.00 and a 1-year high of $0.00.

About Pharmagen

(Get Free Report)

Pharmagen, Inc distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals. It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatitis, and HIV; and specialty products for treating respiratory, oncology, cardiovascular, and hormonal syndromes.

Featured Stories

Receive News & Ratings for Pharmagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharmagen and related companies with MarketBeat.com's FREE daily email newsletter.